Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Raw

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Drug Development and Industrial Pharmacy|June 27, 2009
Generic omeprazole delayed-release capsules: in vitro performance evaluationsTerry Moore, Anjanette Smith, Wei Ye, et al.
The AAPS Journal|June 9, 2012
Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sourcesDavid Awotwe-Otoo, Cyrus Agarabi, David Keire, et al.
Journal of Pharmaceutical Sciences|May 21, 2026
Simulation of nitrosamine drug substance-related impurities from secondary amine-related impurities in approved human drug productsXiang Yu, Jingyue Yang, Ee-Sunn Chia, et al.
Pharmaceutics|May 25, 2024
Effect of Antioxidants in Medicinal Products on Intestinal Drug TransportersChetan P Kulkarni, Jia Yang, Megan L Koleske, et al.
Pharmaceutical Research|May 13, 2003
Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.
Journal of Pharmaceutical Sciences|June 11, 2024
Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug SubstancesDongmei Lu, Bhagwant Rege, Andre Raw, et al.
International Journal of Pharmaceutics|October 16, 2024
Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tabletsDiaa Shakleya, Alaadin Alayoubi, Dustin Brown, et al.
Journal of Pharmaceutical Sciences|June 26, 2023
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide TabletsDiaa Shakleya, Bethel Asmelash, Alaadin Alayoubi, et al.
Pharmaceutical Research|January 8, 2014
Current challenges in bioequivalence, quality, and novel assessment technologies for topical productsAvraham Yacobi, Vinod P Shah, Edward D Bashaw, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Drug Development and Industrial Pharmacy|June 27, 2009
Generic omeprazole delayed-release capsules: in vitro performance evaluationsTerry Moore, Anjanette Smith, Wei Ye, et al.
The AAPS Journal|June 9, 2012
Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sourcesDavid Awotwe-Otoo, Cyrus Agarabi, David Keire, et al.
Journal of Pharmaceutical Sciences|May 21, 2026
Simulation of nitrosamine drug substance-related impurities from secondary amine-related impurities in approved human drug productsXiang Yu, Jingyue Yang, Ee-Sunn Chia, et al.
Pharmaceutics|May 25, 2024
Effect of Antioxidants in Medicinal Products on Intestinal Drug TransportersChetan P Kulkarni, Jia Yang, Megan L Koleske, et al.
Pharmaceutical Research|May 13, 2003
Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applicationsLawrence X Yu, M Scott Furness, Andre Raw, et al.
Journal of Pharmaceutical Sciences|June 11, 2024
Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug SubstancesDongmei Lu, Bhagwant Rege, Andre Raw, et al.
International Journal of Pharmaceutics|October 16, 2024
Nitrosamine mitigation: NDMA impurity formation and its inhibition in metformin hydrochloride tabletsDiaa Shakleya, Alaadin Alayoubi, Dustin Brown, et al.
Journal of Pharmaceutical Sciences|June 26, 2023
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide TabletsDiaa Shakleya, Bethel Asmelash, Alaadin Alayoubi, et al.
Pharmaceutical Research|January 8, 2014
Current challenges in bioequivalence, quality, and novel assessment technologies for topical productsAvraham Yacobi, Vinod P Shah, Edward D Bashaw, et al.
The AAPS Journal|April 5, 2015
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI ConferenceLawrence X Yu, Jeffrey Baker, Susan C Berlam, et al.
Pageof 2